跳至主要内容
临床试验/ACTRN12605000153617
ACTRN12605000153617撤回2 期

The role of Dipyridamole in Improving the False Negative Rate in Pre-Operative Parathyroid Adenoma Localisation Using 99mTc Sestamibi

Robert Williams0 个研究点目标入组 20 人开始时间: 2005年8月15日最近更新:
适应症

试验速览

阶段
2 期
状态
撤回
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Diagnosis
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 ot stated(—)
性别
All

入选标准

  • Previous negative 99mTc Sestamibi parathyroid scan. No subsequent parathyroid surgery. Abnormal parathyroid Hormone (PTH ) levels. Strong clinical suspicion of parathyroid adenoma. Permission of referring doctor. Informed consent of patient.

排除标准

  • Age younger than 18 years, pregnancy, unable to gain informed consent, unstable cardiac disease, Asthma, hypotension, hypersensitivity to aspirin or dipyridamole.

研究者

发起方
Robert Williams

相似试验

已完成
不适用
The effects of oral dipyridamole treatment on the innate immune response during human endotoxemia.Blood poisoning1000401810011954sepsis
NL-OMON34679niversitair Medisch Centrum Sint Radboud30
尚未招募
4 期
Does short dipyridamole administration induce protection against ischemia-reperfusion injury?infarctionischemia reperfusion injury1001108210003216
NL-OMON31190niversitair Medisch Centrum Sint Radboud10
已完成
不适用
Post-Treatment Effects of Dipyridamole On Nucleoside Transport InhibitioIschemia10003216Atherosclerosis
NL-OMON34866Pharmacology-Toxicology14
进行中(未招募)
1 期
The effect of dipyridamole on the pharmacokinetics of metformin.The antihyperglycemic drug metformin and the thrombocyte aggregation inhibitor dipyridamole are often used concomitantly in patients with diabetes who have suffered a transient ischemic attack or stroke. Gastrointestinal absorption of metformin is mediated by the equilibrative nucleoside transporter 4 (hENT4). Dipyridamole has been reported to inhibit hENT4 transport in vitro. Dipyridamole may therefore negatively influence the uptake of metformin from the gastrointestinal tract.MedDRA version: 14.1Level: PTClassification code 10068071Term: Inhibitory drug interactionSystem Organ Class: 10018065 - General disorders and administration site conditionsMedDRA version: 14.1Level: PTClassification code 10013710Term: Drug interactionSystem Organ Class: 10018065 - General disorders and administration site conditions
EUCTR2012-000363-24-NLRadboud University Medical Centre Nijmegen18
招募中
4 期
The effect of dipyridamole on the pharmacokinetics of metformin.geneesmiddeleninteractieDrug interaction
NL-OMON37582niversitair Medisch Centrum Sint Radboud18